Clover Health Investments Corp

Análisis de la acción Clover Health Investments Corp (CLOV)

$4.790

-0.020 (-0.42%)Al cierre

Loading chart…
Máximo
4.890
Apertura
4.760
Precio medio ponderado por volumen
4.81
Volumen
3.73M
Capitalización
645.37M
Mínimo
4.755
Importe
17.95M
EV/EBITDA, TTM
17.36

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.

Análisis de IA of Clover Health Investments Corp (CLOV)

Comprar

Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.

Métricas de valoración

El PER previsto actual de Clover Health Investments Corp (CLOV) es 37.74, frente a su media de 5 años de 3.43.

PER previsto

Valor razonable
Media 5A P/E
3.43
P/E actual
37.74
Sobrevalorada
40.64
Infravalorada
-33.78

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
10.95
EV/EBITDA actual
17.36
Sobrevalorada
30.05
Infravalorada
-8.15

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.55
P/S actual
0.72
Sobrevalorada
0.88
Infravalorada
0.22

Escenarios de precio de Alphio AI para CLOV

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%CLOV

$3.66

Precio del escenario

B

Base

Base · 50%CLOV

$3.60

Precio del escenario

B

Bajista

Bajista · 25%CLOV

$3.51

Precio del escenario

Ballenas con CLOV en cartera

G

GMT Capital Corp.

+ Con en carteraCLOV

+2.52%

Rentabilidad a 3 meses

Cronología de eventos

2026-10-08 (ET)

20:00:00

Nasdaq Composite Falls 1.3% as Tech Stocks Struggle

2026-09-10 (ET)

16:30:00

Major Averages Close Broadly Lower as Oil Surpasses $100

12:30:00

Major Averages Broadly Lower as Oil Surpasses $100

12:30:00

Clover Health Shares Rise 9.1% to $4.74

Noticias

Preguntas frecuentes sobre CLOV, respondidas por Alphio AI

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.

Comunidad

Más ↗
Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar